LEO Pharma and ICON Enter Strategic Partnership


LEO Pharma and ICON have announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective. The mission of the partnership is to improve the lives of dermatology patients with access to innovative clinical trials and the launch of new medicines.

The partnership will leverage both fully outsourced and functional outsourcing models in a hybrid approach. In supporting LEO Pharma through this partnership, ICON will draw upon a team from across its business to deliver tailored solutions, bringing capabilities including its laboratories, Accellacare site-network, FIRECREST site management, and DCT capabilities.


LEO Pharma and ICON Enter a Strategic Partnership to Propel Clinical Trial Execution Within Medical Dermatology. (2023, March 10). Business Wire.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.